Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, G. W.
Right arrow Articles by Shaffer, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gross, G. W.
Right arrow Articles by Shaffer, T. H.

Radiology, Vol 194, 717-720, Copyright © 1995 by Radiological Society of North America

ARTICLES

Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: chest radiographic appearances

GW Gross, JS Greenspan, WW Fox, SD Rubenstein, MR Wolfson and TH Shaffer
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107.

PURPOSE: To assess the effectiveness of performing liquid ventilation with perflubron in neonates with severe respiratory failure or pulmonary hypertension who receive extracorporeal membrane oxygenation (ECMO) life support. MATERIALS AND METHODS: We studied an infant (aged 1 month) and a neonate with respiratory failure who underwent ECMO and liquid ventilation with perflubron, which was slowly instilled via an endotracheal tube (in the infant, 40 mL for more than 1 hour; in the neonate, 28 mL within 1 hour). RESULTS: The infant survived termination of ECMO support and has been breathing room air since 6 months of age. The neonate died soon after ECMO support was withdrawn. CONCLUSION: A minority of neonates or infants with severe respiratory failure or pulmonary hypertension do not respond adequately to treatment with ECMO and are almost certain to die with termination of ECMO support. Liquid ventilation with perflubron offers a potential salvage therapy in this patient population. In addition, perflubron is a good contrast agent to use in the evaluation of neonatal pulmonary abnormalities.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
M.-J. Jeng, D. Trevisanuto, C. M. Weis, W. W. Fox, A. B. Cullen, M. R. Wolfson, and T. H. Shaffer
Role of ventilation strategy on perfluorochemical evaporation from the lungs
J Appl Physiol, April 1, 2001; 90(4): 1365 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. F. Miller, B. Milestone, R. Stern, T. H. Shaffer, and M. R. Wolfson
Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function
J Appl Physiol, March 1, 2001; 90(3): 839 - 849.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. H. Shaffer, R. Foust III, M. R. Wolfson, and T. F. Miller Jr.
Analysis of perfluorochemical elimination from the respiratory system
J Appl Physiol, September 1, 1997; 83(3): 1033 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. S. Greenspan, W. W. Fox, S. D. Rubenstein, M. R. Wolfson, S. S. Spinner, T. H. Shaffer, and Philadelphia Liquid Ventilation Consortium
Partial Liquid Ventilation in Critically Ill Infants Receiving Extracorporeal Life Support
Pediatrics, January 1, 1997; 99(1): e2 - e2.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.